Summary GlobalData’s new report, "Germany Infusion Systems Market Outlook to 2023", provides key market data on the Germany Infusion Systems market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Ambulatory Infusion Pumps, Enteral Infusion Pumps, Implantable Infusion Pumps, Infusion Disposable Set, Syringe Pumps and Volumetric Pumps.
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope - Market size and company share data for Infusion Systems market segments - Ambulatory Infusion Pumps, Enteral Infusion Pumps, Implantable Infusion Pumps, Infusion Disposable Set, Syringe Pumps and Volumetric Pumps. - Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023. - 2016 company shares and distribution shares data for each of the market segments. - Global corporate-level profiles of key companies operating within the Germany Infusion Systems market. - Key players covered include Hospira Inc, Becton Dickinson and Co, Baxter International Inc and Medtronic plc.
Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.\
Our reports have been used by over 10K customers, including:
‘Elastomeric Pumps- Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of elastomeric pumps and the historical and forecasted elastomeric pumps market trends in the US, EU5 (Germany, France, Spain, Italy, and United Kingdom) and Japan.
The elastomeric pumps market report provides...
175 pages •
By The Business Research Company
• Apr 2021
Major players in the injectable drug market are Becton, Dickinson and Company, Gerresheimer AG, Eli Lilly and Company, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Schott AG, Baxter International, Owen Mumford, Mylan N.V., and Sanofi. The global injectable drug delivery devices market is expected to grow from $15.38 billion in 2020...
Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries’ biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities and contrasts...
248 pages •
By Asia Market Information & Development Company
• May 2021
China’s demand for Drug Delivery System has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
Market Overview: The global chitosan market reached a value of US$ 2.49 Billion in 2020. Chitosan is a naturally occurring deacetylated chitin which is extracted from the hard outer-skeleton or shells of shrimps, crabs and lobsters, along with mushrooms and yeasts. It is primarily used as an ingredient in medicines...
The global injectables market is estimated to reach US$759.61 billion in 2025, progressing at a CAGR of 10.95%, over the period 2021-2025. Factors such as increasing geriatric population, upsurge in demand for convenient drug delivery, expanding use of biologics, rising healthcare expenditure and surging incidence of cancer cases would drive...
85 pages •
By Asia Market Information & Development Company
• May 2021
This study focuses on China’s Drug Delivery System industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China...
The major factors for the growth of the novel drug delivery systems (NDDS) market include the growing need of controlled release of drugs, advancement in pharmacology promoting increased adoption of novel drug delivery systems (NDDS), and technological advancements promoting the development of NDDS. There has been a remarkable increase...
Rising prevalence for chronic diseases and growth in the biologics market are expected to drive the overall growth of the pharmaceutical drug delivery market. The global pharmaceutical drug delivery market is projected to reach USD 2,015.3 billion by 2025 from USD 1,430.5 billion in 2020, at a CAGR of 7.1% during the forecast period 2020-2025....
510 pages •
By Roots Analysis Private Ltd.
• May 2020
Chronic diseases, such as diabetes, cardiovascular disorders, neurological disorders, autoimmune disorders and various types of cancer, are known to be the leading causes of death and disability across the world. The clinical conditions associated with these diseases affect patients’ overall quality of life....
Number Of Enterprises
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.